Jean Jacques Bienaime

Director, Keros Therapeutics, Inc.; Director, Immunome Inc.

Bought, 12 months

$0.4M

Sold, 12 months

$0.2M

Companies

Latest trade

Aug 17, 2026

Companies

Keros Therapeutics, Inc.Director +$0.1M Immunome Inc.Director +$0.4M −$0.2M

Trades

KROS Bought 1,000 shares at $10.27 · planned $0.0M Aug 17

KROS Bought 1,000 shares at $10.61 · planned $0.0M Jul 15

KROS Bought 1,000 shares at $10.19 · planned $0.0M Jun 15

IMNM Bought 10,500 shares at $19.45 $0.2M Jun 5

IMNM Sold 10,500 shares at $19.41 $0.2M Jun 5

IMNM Bought 5,000 shares at $20.70 $0.1M May 15

KROS Bought 1,000 shares at $10.58 · planned $0.0M May 15

KROS Bought 1,000 shares at $11.70 · planned $0.0M Apr 15

IMNM Bought 1,000 shares at $21.55 $0.0M Mar 11

IMNM Bought 1,000 shares at $22.12 $0.0M Mar 10

KROS Bought 2,000 shares at $11.21 · planned $0.0M Mar 9

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.